Skip to content
20-F

Annual Report (Foreign)

Achilles Therapeutics plc

0000950170-24-041615

← back to feed
Filed
Apr 4, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2023 · Dec 31, 2023 39.97M sh
Shares Diluted FY 2023 · Dec 31, 2022 39.14M sh
Shares Diluted FY 2023 · Dec 31, 2021 28.65M sh
Shares Outstanding FY 2023 · Dec 31, 2023 41.08M sh
Capex FY 2023 · Dec 31, 2023 $1.1M
Capex FY 2023 · Dec 31, 2022 $7.51M
Capex FY 2023 · Dec 31, 2021 $7.63M
Operating Cash Flow FY 2023 · Dec 31, 2023 −$48.45M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$59.54M
Operating Cash Flow FY 2023 · Dec 31, 2021 −$59.28M
Cash And Equivalents FY 2023 · Dec 31, 2023 $131.54M
Cash And Equivalents FY 2023 · Dec 31, 2022 $173.34M
Cash And Equivalents FY 2023 · Dec 31, 2021 $266.32M
Stockholders Equity FY 2023 · Dec 31, 2023 $142.37M
Stockholders Equity FY 2023 · Dec 31, 2022 $197.04M
Stockholders Equity FY 2023 · Dec 31, 2021 $289.53M
Stockholders Equity FY 2023 · Dec 31, 2020 $189.37M
Current Liabilities FY 2023 · Dec 31, 2023 $17M
Current Liabilities FY 2023 · Dec 31, 2022 $17.99M
Total Liabilities FY 2023 · Dec 31, 2023 $19.09M
Total Liabilities FY 2023 · Dec 31, 2022 $23.31M
Current Assets FY 2023 · Dec 31, 2023 $145.63M
Current Assets FY 2023 · Dec 31, 2022 $196.58M
Total Assets FY 2023 · Dec 31, 2023 $161.46M
Total Assets FY 2023 · Dec 31, 2022 $220.36M
Eps Diluted FY 2023 · Dec 31, 2023 −$1.74
Eps Diluted FY 2023 · Dec 31, 2022 −$1.82
Eps Diluted FY 2023 · Dec 31, 2021 −$2.13
Eps Basic FY 2023 · Dec 31, 2023 −$1.74
Eps Basic FY 2023 · Dec 31, 2022 −$1.82
Eps Basic FY 2023 · Dec 31, 2021 −$2.13
Sga Expense FY 2023 · Dec 31, 2023 $17.01M
Sga Expense FY 2023 · Dec 31, 2022 $21.12M
Sga Expense FY 2023 · Dec 31, 2021 $21.97M
Rd Expense FY 2023 · Dec 31, 2023 $58.25M
Rd Expense FY 2023 · Dec 31, 2022 $57.26M
Rd Expense FY 2023 · Dec 31, 2021 $42.22M
Net Income FY 2023 · Dec 31, 2023 −$69.67M
Net Income FY 2023 · Dec 31, 2022 −$71.18M
Net Income FY 2023 · Dec 31, 2021 −$61.1M
Operating Income FY 2023 · Dec 31, 2023 −$75.26M
Operating Income FY 2023 · Dec 31, 2022 −$78.38M
Operating Income FY 2023 · Dec 31, 2021 −$64.2M